No abstract available.
Fever* ; Hemoptysis*

No abstract available.
Child* ; Growth Hormone* ; Humans

No abstract available.
Hyperparathyroidism, Primary

Congenital hypothyroidism is one of the most common endocrine disease in childhood and it causes not only mental retardation but also growth retardation. There were many papers about evaluation of developmental outcome in congenital hypothyroidism. The aim of this study was to evaluate growth outcome in congenital hypothyroidism. We evaluated 65 patients with congenital hypothyroidism diagnosed at Yonsei University College of Medicine. The results were summerized as follows; 1) The Male to female ratio was 1:1.4 2) Among the 65 patients, under 1 year of age with 16 cases (24.6%), 1~4 years with 19 cases (29.2%), 5~10 years with 22 cases (33.8%), above 10 years with 8 cases (12.3%). 3) Among the 65 patients, 30 cases (46%) had ectopic thyroid, 18 cases (28%) had dyshormonogeneses, 10 cases (15%) had hypoplasia and 7 cases (11%) had aplasia. 4) At the initial diagnosis, all the patients showed decreased T3, T4 and increased TSH level. 5) Before treatment, bone age and height age were delayed but they were normalized after treatment. 6) There was correlation between age of initial treatment and current height percentile. 7) There was significant correlation between initial T3 level and height age delay. 8) In the 4 cases who were diagnosed and treated before the age of 4, final adult height would be achieved within normal range. In conclusion, delayed growth due to congenital hypothyroidism would be prevented by early diagnosis and treatment. Therefore, the recognition of the importance of early diagnosis and treatment is emphasized.
Adult ; Congenital Hypothyroidism* ; Diagnosis ; Early Diagnosis ; Endocrine System Diseases ; Female ; Humans ; Intellectual Disability ; Male ; Reference Values ; Thyroid Dysgenesis

No abstract available.

PURPOSE: This paper reports the results of a massage therapy on transcutaneous bilirubin (TcB) in the forehead and inguinal regions, feeding intake, urine amount, and defecation frequency for neonates with jaundice who are receiving phototherapy. METHODS: A non-equivalent control group, pre-post, quasi-experimental design was used. Participants were 33 neonates with jaundice admitted for phototherapy and were randomly assigned to one of two groups—an experimental group (n=16), which received 3 days of routine plus 15 minutes of massage three times a day, and a control group (n=17), which received the routine care only. Data were analyzed using χ²-test and Mann-Whitney U test with SPSS 21.0 Win program. RESULTS: On the second day of hospitalization, the experimental group showed significantly lower TcB in the inguinal region (Z=−2.12, p=0.017); on the third day, the experimental group showed significantly lower TcB in the inguinal region (Z=−2.31, p=0.011) and higher defecation frequency (Z=−2.22, p=0.013) compared with the control group. CONCLUSIONS: The study findings suggest that massage for jaundice neonates receiving phototherapy is an effective intervention to reduce TcB in the inguinal region and to increase defecation frequency.
Bilirubin ; Defecation ; Forehead ; Hospitalization ; Humans ; Infant ; Infant, Newborn ; Jaundice ; Massage ; Phototherapy

Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for nearly half of the cases of HF and its incidence might be increasing with the aging society. Patients with HFpEF present with significant symptoms, including exercise intolerance, impaired quality of life, and have a poor prognosis as well as frequent hospitalization and increased mortality compared with HF with reduced ejection fraction. The concept of HFpEF is still evolving and may be a virtual complex rather than a real systemic disorder. Thus, beyond solely targeting cardiac abnormalities management strategies need to be extended, such as left ventricular diastolic dysfunction. In this review, we examine new diagnostic algorithms, pathophysiology, current management status, and ongoing trials based on heterogeneous pathophysiology and etiology in HFpEF.

Obesity is associated with an impairment of the growth hormone secretion elicited by all stimuli known to date, but the basic mechanism of the alteration is unknown to date, but the basic mechanism of this alteration is unknown. To determine whether obesity is associated with a chronic state of tonic somatostatin secretion, several tests with growth hormone stimuli such as GHRH(1 microgram/kg), clonidine(150 microgram/m(2))and Regular insulin (0.1U/kg, subcutaneously), to obese subjects and normal control with or without pyridostigmine were undertaken, and the Somatomedin-c levels were measured in both obese subjects and matched controls. 1) The peak GH levels and AUC-GH after administration of GHRH, Clonidine or Regular insulin in obese group is less than those in control group. 2) Pretreatment with pyridostigmine increased the peak GH levels and AUC-GH significantly in obese group but the absolute values are less than those of normal group. 3) The Somatomedin-c levels are significantly higher in obese group than control. Our results lend support to the view that chronically high level of somatostatin decreases the responsiveness to GHRH and secretion itself.
Child* ; Clonidine ; Growth Hormone* ; Humans ; Insulin ; Obesity* ; Pyridostigmine Bromide ; Somatostatin

No abstract available.
Animals ; In Situ Hybridization* ; Linoleic Acid* ; Mice*